Prealize – Precision Healthcare
Linda Hand, CEO of Prealize, discusses the use of AI and machine learning to pinpoint individuals and populations most likely to have a significant health event over the next 12-18 months that will benefit from early intervention. She also talks about the post-pandemic healthcare surge and precision public health.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Healthcare. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Healthcare and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Healthcare?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Linda Hand, CEO of Prealize, discusses the use of AI and machine learning to pinpoint individuals and populations most likely to have a significant health event over the next 12…
- Key Point: She also talks about the post-pandemic healthcare surge and precision public health.
- Key Point: Hand brings 35 years’ experience to her role as CEO of Prealize, with an emphasis in organizational leadership, product development, solutions delivery and go-to-market strate…
- Key Point: Previously, Linda led the Clinical Trial Optimization Solutions division at IQVIA, where she was responsible for creating and delivering a suite of innovative clinical technolog…
- Key Point: She is the past president and CEO of the San Francisco-based DecisionView, the leading provider of clinical trial enrollment optimization solutions.
Linda T. Hand brings 35 years’ experience to her role as CEO of Prealize, with an emphasis in organizational leadership, product development, solutions delivery and go-to-market strategies across a diverse portfolio of industries. Previously, Linda led the Clinical Trial Optimization Solutions division at IQVIA, where she was responsible for creating and delivering a suite of innovative clinical technology products, fueled by predictive analytics and machine learning algorithms, to drug development organizations worldwide. She is the past president and CEO of the San Francisco-based DecisionView, the leading provider of clinical trial enrollment optimization solutions. She also ran product development and delivery at a number of leading software companies, including DigitalThink, Hyperion, Arbor Software and Sybase. Linda holds a BA in Computer Science from the University of California, Berkeley, and completed the Haas School of Business Executive Program.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

